Order Article Reprints

Ehlers FAI, Beelen NA, van Gelder M, Evers TMJ, Smidt ML, Kooreman LFS, Bos GMJ, Wieten L. ADCC-Inducing Antibody Trastuzumab and Selection of KIR-HLA Ligand Mismatched Donors Enhance the NK Cell Anti-Breast Cancer Response. Cancers. 2021; 13(13):3232. https://doi.org/10.3390/cancers13133232

Ehlers, Femke A. I., Nicky A. Beelen, Michel van Gelder, Tom M. J. Evers, Marjolein L. Smidt, Loes F. S. Kooreman, Gerard M. J. Bos, and Lotte Wieten. 2021. "ADCC-Inducing Antibody Trastuzumab and Selection of KIR-HLA Ligand Mismatched Donors Enhance the NK Cell Anti-Breast Cancer Response" Cancers 13, no. 13: 3232. https://doi.org/10.3390/cancers13133232

Ehlers, F. A. I., Beelen, N. A., van Gelder, M., Evers, T. M. J., Smidt, M. L., Kooreman, L. F. S., Bos, G. M. J., & Wieten, L. (2021). ADCC-Inducing Antibody Trastuzumab and Selection of KIR-HLA Ligand Mismatched Donors Enhance the NK Cell Anti-Breast Cancer Response. Cancers, 13(13), 3232. https://doi.org/10.3390/cancers13133232